You are here

Article info

Article menu
Download PDFPDF
Original research
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer

Authors

  • Thomas Bartl Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Wien, Austria Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Anita Alberts Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Sofia-Christina Papadopoulos Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Andrea Wolf Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Leonhard Muellauer Department of Pathology, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Gerda Hofstetter Department of Pathology, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Christoph Grimm Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  • Dan Cacsire Castillo-Tong Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Wien, Austria PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Dan Cacsire Castillo-Tong, Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Wien 1090, Austria; dan.cacsire-castillo{at}meduniwien.ac.at
View Full Text

Citation

Bartl T, Alberts A, Papadopoulos S, et al
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer
International Journal of Gynecologic Cancer 2023;33:1419-1426.

Publication history

  • Received February 7, 2023
  • Accepted April 10, 2023
  • First published April 24, 2023.
Online issue publication 
February 12, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.